Performance of a Translucent Activator for LipiFlow Vectored Thermal Pulse (VTP) Treatment of Meibomian Gland Dysfunction

References

• Nichols K, Foulks G, Bron A, et al. The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci. 2011;52:1922–1929. doi:10.1167/iovs.10-6997a
   PubMed Web of Science ®Google Scholar
• Qiao J, Yan X. Emerging treatment options for meibomian gland dysfunction. Clin Ophthalmol. 2013;7:1797–1803. doi:10.2147/OPTH.S33182
   PubMedGoogle Scholar
• Johnson & Johnson Vision Care, Inc. and Johnson & Johnson Surgical Vision, Inc; 2021. TearScience® LipiFlow® Thermal Pulsation System. Available from: https://www.jnjvisionpro.com/products/eye-medical-devices/lipiflow-treatment.
   Google Scholar
• Godin M, Stinnett S, Gupta P. Outcomes of thermal pulsation treatment for dry eye syndrome in patients with Sjogren disease. Cornea. 2018;37:1155–1158. doi:10.1097/ICO.0000000000001621
   PubMed Web of Science ®Google Scholar
• Kenrick C, Alloo S. The limitation of applying heat to the external lid surface: a case of recalcitrant meibomian gland dysfunction. Case Rep Ophthalmol. 2017;8:7–12. doi:10.1159/000455087
   PubMed Web of Science ®Google Scholar
• Korb D, Blackie C. Case report: a successful LipiFlow treatment of a single case of meibomian gland dysfunction and dropout. Eye Contact Lens. 2013;39:e1–3. doi:10.1097/ICL.0b013e31824ccbda
   PubMed Web of Science ®Google Scholar
• Schallhorn C, Schallhorn J, Hannan S, et al. Effectiveness of an eyelid thermal pulsation procedure to treat recalcitrant dry eye symptoms after laser vision correction. J Refract Surg. 2017;33:30–36. doi:10.3928/1081597X-20161006-05
   PubMed Web of Science ®Google Scholar
• Blackie C, Coleman C, Nichols K, et al. A single vectored thermal pulsation treatment for meibomian gland dysfunction increases mean comfortable contact lens wearing time by approximately 4 hours per day. Clin Ophthalmol. 2018;12:169–183. doi:10.2147/OPTH.S153297
   PubMed Web of Science ®Google Scholar
• Blackie CA, Coleman CA, Holland E. The sustained effect (12 months) of a single-dose vectored thermal pulsation procedure for meibomian gland dysfunction and evaporative dry eye. Clin Ophthalmol. 2016;10:1385–1396. doi:10.2147/OPTH.S109663
   PubMed Web of Science ®Google Scholar
• Finis D, Hayajneh J, König C, et al. Evaluation of an automated thermodynamic treatment (Lipiflow®) system for meibomian gland dysfunction: a prospective, randomized, observer-masked trial. Ocul Surf. 2014;12:146–154. doi:10.1016/j.jtos.2013.12.001
   PubMed Web of Science ®Google Scholar
• Hagen KB, Bedi R, Blackie CA, et al. Comparison of a single-dose vectored thermal pulsation procedure with a 3-month course of daily oral doxycycline for moderate-to-severe meibomian gland dysfunction. Clin Ophthalmol. 2018;12:161–168. doi:10.2147/OPTH.S150433
   PubMed Web of Science ®Google Scholar
• Kasetsuwan N, Suwajanakorn D, Tantipat C, et al. The efficacy between conventional lid hygiene and additional thermal pulsatile system in meibomian gland dysfunction patients treated with long-term anti-glaucoma medications in a randomized controlled trial. Clin Ophthalmol. 2020;14:2891–2902. doi:10.2147/OPTH.S259692
   PubMed Web of Science ®Google Scholar
• Lane SS, DuBiner HB, Epstein RJ, et al. A new system, the LipiFlow, for the treatment of meibomian gland dysfunction. Cornea. 2012;31:396–404. doi:10.1097/ICO.0b013e318239aaea
   PubMed Web of Science ®Google Scholar
• Tauber J, Owen J, Bloomenstein M, et al. Comparison of the iLUX and the lipiflow for the treatment of meibomian gland dysfunction and symptoms: a randomized clinical trial. Clin Ophthalmol. 2020;14:405–418. doi:10.2147/OPTH.S234008
   PubMed Web of Science ®Google Scholar
• Zhao Y, Veerappan A, Yeo S, et al. Clinical trial of thermal pulsation (LipiFlow) in meibomian gland dysfunction with pretreatment meibography. Eye Contact Lens. 2016;42:339–346. doi:10.1097/ICL.0000000000000228
   PubMed Web of Science ®Google Scholar
• Zhao Y, Xie J, Li J. Evaluation of monocular treatment for meibomian gland dysfunction with an automated thermodynamic system in elderly Chinese patients: a contralateral eye study. J Ophthalmol. 2016;27:1–8.
   Google Scholar
• Chan A, Chuang J, Wong V. Evaluation of meibomian gland dysfunction among ophthalmic healthcare workers. Clin Ophthalmol. 2021;15:1201–1206. doi:10.2147/OPTH.S299338
   PubMed Web of Science ®Google Scholar
• Finis D, König C, Hayajneh J, et al. Six-month effects of a thermodynamic treatment for MGD and implications of meibomian gland atrophy. Cornea. 2014;33:1265–1270. doi:10.1097/ICO.0000000000000273
   PubMed Web of Science ®Google Scholar
• Greiner J. A single LipiFlow® Thermal Pulsation System treatment improves meibomian gland function and reduces dry eye symptoms for 9 months. Curr Eye Res. 2012;37:272–278. doi:10.3109/02713683.2011.631721
   PubMed Web of Science ®Google Scholar
• Greiner J. Long-term (3 year) effects of a single thermal pulsation system treatment on meibomian gland function and dry eye symptoms. Eye Contact Lens. 2016;42:99–107. doi:10.1097/ICL.0000000000000166
   PubMed Web of Science ®Google Scholar
• Kim M, Stinnett S, Gupta P. Effect of thermal pulsation treatment on tear film parameters in dry eye disease patients. Clin Ophthalmol. 2017;11:883–886. doi:10.2147/OPTH.S136203
   PubMed Web of Science ®Google Scholar
• O’Neil E, Henderson M, Massaro-Giordano M, et al. Advances in dry eye disease treatment. Curr Opin Ophthalmol. 2019;30:166–178. doi:10.1097/ICU.0000000000000569
   PubMed Web of Science ®Google Scholar
• Geerling G, Baudouin C, Aragona P, et al. Emerging strategies for the diagnosis and treatment of meibomian gland dysfunction: proceedings of the OCEAN group meeting. Ocul Surf. 2017;15:179–192.
   PubMed Web of Science ®Google Scholar
• Pang S, Chen Y, Tam K, et al. Efficacy of vectored thermal pulsation and warm compress treatments in meibomian gland dysfunction: a meta-analysis of randomized controlled trials. Cornea. 2019;38:690–697. doi:10.1097/ICO.0000000000001907
   PubMed Web of Science ®Google Scholar
• Arita R, Fukuoka S. Non-pharmaceutical treatment options for meibomian gland dysfunction. Clin Exp Optom. 2020;103:742–755. doi:10.1111/cxo.13035
   PubMed Web of Science ®Google Scholar
• Mandal P, Khan M, Shah S. Drugs - Do we need them? Applications of non-pharmaceutical therapy in anterior eye disease: a review. Cont Lens Anterior Eye. 2017;40:360–366. doi:10.1016/j.clae.2017.09.001
   PubMed Web of Science ®Google Scholar
• Sabeti S, Kheirkhah A, Yin J, et al. Management of meibomian gland dysfunction: a review. Surv Ophthalmol. 2020;65:205–217. doi:10.1016/j.survophthal.2019.08.007
   PubMed Web of Science ®Google Scholar
• Villani E, Marelli L, Dellavalle A, et al. Latest evidences on meibomian gland dysfunction diagnosis and management. Ocul Surf. 2020;18:871–892. doi:10.1016/j.jtos.2020.09.001
   PubMed Web of Science ®Google Scholar
• Lemp M. Report of the National Eye Institute/industry workshop on clinical trials in dry eyes. CLAO J. 1995;21:221–232.
   PubMedGoogle Scholar
• Blackie C, Carlson A, Korb D. Treatment for meibomian gland dysfunction and dry eye symptoms with a single-dose vectored thermal pulsation: a review. Curr Opin Ophthalmol. 2015;26:306–313. doi:10.1097/ICU.0000000000000165
   PubMed Web of Science ®Google Scholar
• Hovanesian J, Bullimore M, Tauber J, et al. Comparison of the iLUX and the LipiFlow for the treatment of meibomian gland dysfunction and symptoms: a randomized clinical trial. Clin Ophthalmol. 2020;14:405–418.
   PubMed Web of Science ®Google Scholar